Switch theme
Sign up to access all valuation multiples
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .
1998
58
LTM Revenue $11.1M
LTM EBITDA n/a
$28.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Durect has a last 12-month revenue of $11.1M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Durect achieved revenue of $8.5M and an EBITDA of -$24.8M.
Durect expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Durect valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $8.5M | $12.9M | XXX | XXX | XXX |
| Gross Profit | $12.0M | $17.7M | XXX | XXX | XXX |
| Gross Margin | 141% | 137% | XXX | XXX | XXX |
| EBITDA | -$24.8M | n/a | XXX | XXX | XXX |
| EBITDA Margin | -290% | NaN% | XXX | XXX | XXX |
| Net Profit | -$36.3M | -$35.3M | XXX | XXX | XXX |
| Net Margin | -424% | -273% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of March 13, 2025, Durect's stock price is $1.
Durect has current market cap of $24.8M, and EV of $28.2M.
See Durect trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $28.2M | $24.8M | XXX | XXX | XXX | XXX | $-0.50 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of March 13, 2025, Durect has market cap of $24.8M and EV of $28.2M.
Durect's trades at 2.5x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Durect's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Durect and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $28.2M | XXX | XXX | XXX |
| EV/Revenue | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | XXX | XXX |
| P/E | -1.6x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpDurect's NTM/LTM revenue growth is -37%
Durect's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.8M for the same period.
Over next 12 months, Durect's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Durect's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Durect and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 51% | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.8M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 343% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 511% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Durect acquired XXX companies to date.
Last acquisition by Durect was XXXXXXXX, XXXXX XXXXX XXXXXX . Durect acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Durect founded? | Durect was founded in 1998. |
| Where is Durect headquartered? | Durect is headquartered in United States of America. |
| How many employees does Durect have? | As of today, Durect has 58 employees. |
| Who is the CEO of Durect? | Durect's CEO is Mr. James E. Brown,D.V.M.. |
| Is Durect publicy listed? | Yes, Durect is a public company listed on NAS. |
| What is the stock symbol of Durect? | Durect trades under DRRX ticker. |
| When did Durect go public? | Durect went public in 2000. |
| Who are competitors of Durect? | Similar companies to Durect include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Durect? | Durect's current market cap is $24.8M |
| What is the current revenue of Durect? | Durect's last 12-month revenue is $11.1M. |
| What is the current EV/Revenue multiple of Durect? | Current revenue multiple of Durect is 2.5x. |
| What is the current revenue growth of Durect? | Durect revenue growth between 2023 and 2024 was 51%. |
| Is Durect profitable? | Yes, Durect is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
